A Double-Blind Placebo-Control Dose Escalating Study to Evaluate the Safety and Immunogenicity of dmLT by Oral, Sublingual and Intradermal Vaccination in Adults Residing in an Endemic Area
Clinical trial NCT03548064 · TERMINATED
Trial details
- NCT number
- NCT03548064
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-10
- Primary completion
- 2020-12-31
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.